Neurocrine Biosciences reported $322M in Debt for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Abbvie ABBV:US $ 85530M 526M
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 236.9M 2.1M
Adamas Pharmaceuticals ADMS:US 129.74M 225K
Agios Pharmaceuticals AGIO:US $ 1.01M 0.44M
Alexion Pharmaceuticals ALXN:US $ 2532M 30M
ALKERMES ALKS:US $ 297.07M 0.63M
Alnylam Pharmaceuticals ALNY:US $ 191.59M 0.31M
Amgen AMGN:US $ 32685M 301M
Aptinyx Inc APTX:US $ 0 0
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Cytokinetics CYTK:US $ 137.39M 1.68M
Dynavax Technologies DVAX:US $ 179.89M 0.08M
Enanta Pharmaceuticals ENTA:US $ 1.48M 0M
Gw Pharmaceuticals GWPH:US $ 15.19M 0.11M
Halozyme Therapeutics HALO:US $ 873.77M 476.54M
Intra Cellular Therapies ITCI:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 322M 4.1M
Prothena PRTA:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 2696.7M 1M
Rigel Pharmaceuticals RIGL:US $ 19.84M 0.03M
Sarepta Therapeutics SRPT:US $ 1091.11M 98.62M
Teva Pharmaceutical TEVA:IT 25.13B 147M
Ultragenyx Pharmaceutical RARE:US $ 0M 1.16M
Vertex Pharmaceuticals VRTX:US $ 569.75M 39.42M
Xoma XOMA:US $ 18.86M 2M
YTE INCY:US $ 34.47M 0.39M